Brad Hively, Director at Oncology Institute, Inc. (TOI), bought 9,056 shares at $1.04 ($9K) on 2025-03-26, disclosed to the SEC on 2025-03-28.
Open-market purchase of $9k TOI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| TOI | SELL | 2025-08-21 | $164K | — | Filing → |
| TOI | SELL | 2025-06-05 | $11.3M | — | Filing → |
| TOI | BUY | 2025-04-28 | $47K | — | Filing → |